86 related articles for article (PubMed ID: 27393730)
1. [Not Available].
Frauger E; Vigneau C; Orléans V; Thirion X; Jolliet P; Micallef J; le Réseau des Ceip
Therapie; 2008; 63(2):119-27. PubMed ID: 27393730
[TBL] [Abstract][Full Text] [Related]
2. [Consumption of cannabis among subjects with history of abuse/dependence or under an opiate maintenance therapy: OPPIDUM data in 2006 and main trends since 2004].
Frauger E; Vigneau C; Orléans V; Thirion X; Jolliet P; Micallef J; Réseau des CEIP
Therapie; 2008; 63(2):119-27. PubMed ID: 18561886
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of addictive behaviours among new prisoners in France using the OPPIDUM program].
Pauly V; Frauger E; Rouby F; Sirere S; Monier S; Paulet C; Gibaga V; Micallef J; Thirion X
Encephale; 2010 Apr; 36(2):122-31. PubMed ID: 20434629
[TBL] [Abstract][Full Text] [Related]
4. [Surveillance system on drug abuse: Interest of the French national OPPIDUM program of French addictovigilance network].
Frauger E; Pochard L; Boucherie Q; Giocanti A; Chevallier C; Daveluy A; Gibaja V; Caous AS; Eiden C; Authier N; Le Boisselier R; Guerlais M; Jouanjus É; Lepelley M; Pizzoglio V; Pain S; Richard N; Micallef J;
Therapie; 2017 Sep; 72(4):491-501. PubMed ID: 28343650
[TBL] [Abstract][Full Text] [Related]
5. [Comorbidity in 207 cannabis users in a specific outpatient setting].
Guillem E; Arbabzadeh-Bouchez S; Vorspan F; Bellivier F
Encephale; 2015 Jun; 41 Suppl 1():S7-12. PubMed ID: 25123065
[TBL] [Abstract][Full Text] [Related]
6. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
[TBL] [Abstract][Full Text] [Related]
7. Which psychoactive prescription drugs are illegally obtained and through which ways of acquisition? About OPPIDUM survey.
Frauger E; Nordmann S; Orleans V; Pradel V; Pauly V; Thirion X; Micallef J;
Fundam Clin Pharmacol; 2012 Aug; 26(4):549-56. PubMed ID: 21564282
[TBL] [Abstract][Full Text] [Related]
8. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
Liraud F; Verdoux H
Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
[TBL] [Abstract][Full Text] [Related]
9. [Student's use of illicit drugs: a survey in a preventive health service].
Morvan Y; Rouvier J; Olié JP; Lôo H; Krebs MO
Encephale; 2009 Dec; 35 Suppl 6():S202-8. PubMed ID: 20141772
[TBL] [Abstract][Full Text] [Related]
10. OPPIDUM surveillance program: 20 years of information on drug abuse in France.
Frauger E; Moracchini C; Le Boisselier R; Braunstein D; Thirion X; Micallef J;
Fundam Clin Pharmacol; 2013 Dec; 27(6):672-82. PubMed ID: 23510229
[TBL] [Abstract][Full Text] [Related]
11. [Self-esteem, coping, perceived social support and substance use in young adults with a cannabis dependence disorder].
Dorard G; Bungener C; Corcos M; Berthoz S
Encephale; 2014 Jun; 40(3):255-62. PubMed ID: 23928065
[TBL] [Abstract][Full Text] [Related]
12. [Acting out and psychoactive substances: alcohol, drugs, illicit substances].
Gillet C; Polard E; Mauduit N; Allain H
Encephale; 2001; 27(4):351-9. PubMed ID: 11686057
[TBL] [Abstract][Full Text] [Related]
13. A drug policy for our times.
Nahas GG; Frick HC; Gleaton T; Schuchard K; Moulton O
Bull Narc; 1986; 38(1-2):3-14. PubMed ID: 3779179
[TBL] [Abstract][Full Text] [Related]
14. Relationship between working-memory network function and substance use: a 3-year longitudinal fMRI study in heavy cannabis users and controls.
Cousijn J; Vingerhoets WA; Koenders L; de Haan L; van den Brink W; Wiers RW; Goudriaan AE
Addict Biol; 2014 Mar; 19(2):282-93. PubMed ID: 24589297
[TBL] [Abstract][Full Text] [Related]
15. Consumption of psychoactive substances among 535 women entering a Lyon prison (France) between June 2004 and December 2008.
Sahajian F; Lamothe P; Fabry J; Vanhems P
Rev Epidemiol Sante Publique; 2012 Oct; 60(5):371-81. PubMed ID: 22981309
[TBL] [Abstract][Full Text] [Related]
16. Misuse of buprenorphine maintenance treatment since introduction of its generic forms: OPPIDUM survey.
Nordmann S; Frauger E; Pauly V; Orléans V; Pradel V; Mallaret M; Thirion X; Micallef J
Pharmacoepidemiol Drug Saf; 2012 Feb; 21(2):184-90. PubMed ID: 22109894
[TBL] [Abstract][Full Text] [Related]
17. [Motivations for cannabis cessation, coping and adaptation strategies, and perceived benefits: impact on cannabis use relapse and abstinence].
Chauchard E; Septfons A; Chabrol H
Encephale; 2013 Dec; 39(6):385-92. PubMed ID: 23928064
[TBL] [Abstract][Full Text] [Related]
18. Heavy cannabis users seeking treatment- prevalence of psychiatric disorders.
Arendt M; Munk-Jørgensen P
Soc Psychiatry Psychiatr Epidemiol; 2004 Feb; 39(2):97-105. PubMed ID: 15052390
[TBL] [Abstract][Full Text] [Related]
19. [The use of cannabis in the Federal Republic of Germany].
Tossmann P
Prax Kinderpsychol Kinderpsychiatr; 2006; 55(7):509-19. PubMed ID: 17058777
[TBL] [Abstract][Full Text] [Related]
20. Cannabis use in the community.
Robertson JR; Miller P; Anderson R
Br J Gen Pract; 1996 Nov; 46(412):671-4. PubMed ID: 8978114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
